The Ultimate Guide to AAPA Category 1 Pharmacology Credit: Everything You Need to Succeed

As a Physician Assistant, managing your professional development budget requires strategic planning. June is a critical month for the medical community. For many PAs and healthcare providers, June 30 marks the expiration date for annual CME stipends and professional development funds. If you do not utilize these funds by the end of the month, you lose the opportunity to invest in your clinical knowledge and licensure requirements.

Securing AAPA Category 1 Pharmacology Credit is a high-priority task for PAs, especially those practicing in states with specific prescriptive authority requirements. Our Pharmacology CME Review Package provides an efficient, high-yield solution to meet these needs before the June 30 deadline.

Pharmacology CME Review Logistics

Price: $399.99
Access: 30 months of on-demand access
Deliverables: 12 AAPA Category 1 Self-Assessment CME Credits, 120-question bank, pharmacology lecture videos, and gift card add-on options.

Understanding the Value of Self-Assessment Credits

The Pharmacology CME Review Package at CME Review Courses is designated for 12 AAPA Category 1 Self-Assessment CME credits. For PAs maintaining NCCPA certification, these credits offer a distinct advantage. The NCCPA applies a 50 percent weighting bonus to self-assessment credits. This means that logging these 12 credits automatically results in 18 credits toward your certification maintenance.

While the PANRE Review Course provides 100 hours of AAPA Category 1 credit, the Pharmacology course is specifically tailored to the nuances of medication management and prescriptive regulation.

Why Pharmacology Credits Matter for Your License

Licensure requirements vary by state. While every PA needs Category 1 CME, several states mandate a specific number of pharmacology-focused hours to maintain prescriptive privileges:

• Maryland: Requires a minimum of 8 hours in pharmacology.
• Massachusetts: Requires 4 hours related to pharmacology for PAs with prescriptive authority.
• Georgia: Mandates 3 hours of practice-specific pharmaceutical education.
• Ohio: Requires 12 hours of pharmacology CE for license renewal.

By choosing a dedicated pharmacology review, you satisfy both the general Category 1 requirement and the specific prescriptive mandates of your state board. This course is also beneficial for Nurse Practitioners. The AANP recognizes AAPA Category 1 credit as an acceptable source for advanced nursing CE content, though NPs should verify specific state board requirements.

Maximizing Your Stipend with Gift Card Add-Ons

One of the most effective ways to utilize a remaining CME stipend is through our CME with Gift Card packages. This allows you to add an Amazon or Apple Gift Card ranging from $100 to $1500 to your purchase.

This setup enables you to bundle your educational costs with a gift card that can be used for further professional enrichment, such as purchasing medical equipment, textbooks, or technology for your practice. The total price is reflected in a single transaction, making it a streamlined way to exhaust your 2026 CME budget before it expires on June 30.

Clinical Content and High-Yield Review

The Pharmacology Review Course covers essential topics across multiple specialties, including:

• Cardiology (Antihypertensives, Antiarrhythmics)
• Endocrinology (Diabetes management, Thyroid agents)
• Infectious Disease (Antibiotic stewardship)
• Neurology and Psychiatry (Antiepileptics, Psychotropics)
• Emergency Medicine and Orthopedics (Pain management, Muscle relaxants)

The 120-question bank is designed to simulate real-world clinical decision-making. Below is an example of the clinical vignette format you will encounter in the course.

Clinical Vignette: Endocrinology Pharmacology

Your patient is a 54-year-old male with a history of Type 2 Diabetes Mellitus (T2DM) and a recent diagnosis of Heart Failure with Reduced Ejection Fraction (HFrEF). His current HbA1c is 7.8% despite adherence to Metformin 1,000 mg twice daily. He has no history of recurrent urinary tract infections or chronic kidney disease (eGFR is 55 mL/min/1.73m²). Physical exam reveals 1+ pitting edema in the lower extremities.

Which of the following medications is the most appropriate next step in management to improve both his glycemic control and reduce the risk of heart failure hospitalization?

A) Pioglitazone
B) Empagliflozin
C) Sitagliptin
D) Glipizide

Explanation

The correct answer is B) Empagliflozin.

Empagliflozin, an SGLT2 inhibitor, is the preferred agent in patients with T2DM and concomitant heart failure. Clinical trials have demonstrated that SGLT2 inhibitors significantly reduce the risk of hospitalization for heart failure and provide cardiovascular benefits independent of their glucose-lowering effects.

• Pioglitazone (A) is contraindicated in patients with symptomatic heart failure as it can cause fluid retention and exacerbate the condition.
• Sitagliptin (C), a DPP-4 inhibitor, is generally weight-neutral and safe, but saxagliptin (within the same class) has been associated with increased HF hospitalizations. Sitagliptin does not provide the robust heart failure benefits seen with SGLT2 inhibitors.
• Glipizide (D) is a sulfonylurea which effectively lowers blood glucose but carries a risk of hypoglycemia and weight gain, with no specific cardiovascular or heart failure benefits.

Act Now Before June 30

The Pharmacology CME Review Course offers a pragmatic approach to clinical excellence and regulatory compliance. With 30 months of access, you can secure your credits now and refer back to the materials as needed in your daily practice.

Don't let your 2026 CME stipend expire. Invest in a course written by PAs for PAs that provides tangible value through both education and gift card add-ons.

Enroll in the Pharmacology CME Review Package Today